文献速递先天性心脏病外科瓣膜外科

法洛四联症修复后肺动脉瓣置换年龄超过35岁与死亡率增加相关:英国国家先天性心脏病审计数据库结果

Age over 35 years is associated with increased mortality after pulmonary valve replacement in repaired tetralogy of Fallot: results from the UK National Congenital Heart Disease Audit database.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

本研究为英国国家多中心回顾性研究,纳入2000至2013年间首次行肺动脉瓣置换的707例>15岁法洛四联症修复后患者,中位年龄26岁。Cox回归和分类回归树分析确定35岁为最佳年龄截断值,>35岁患者10年死亡风险为<35岁者的5.6倍(10.4% vs 1.3%,P<0.001)。结论提示部分患者首次肺动脉瓣置换时机仍不理想,需重新评估干预标准。

要点

  • 法洛四联症修复后首次肺动脉瓣置换年龄>35岁与10年死亡率显著增加相关
  • >35岁患者合并三尖瓣修复/置换及外科心律失常治疗的比例更高
  • 需重新评估法洛四联症修复后肺动脉瓣置换的干预时机标准

核心结论

  • 法洛四联症修复后首次肺动脉瓣置换年龄>35岁患者10年死亡率显著高于年轻患者,且相对于一般人群的死亡负担更高。
  • 研究提示部分患者首次肺动脉瓣置换时机仍不理想,需重新评估干预标准。

研究设计与样本

  • 英国国家多中心回顾性研究,纳入2000至2013年间首次行肺动脉瓣置换的>15岁法洛四联症修复后患者707例,中位年龄26(15-72)岁。
  • 采用Cox回归和分类回归树分析确定最佳年龄截断值。

主要发现

  • 肺动脉瓣置换后10年死亡率为4.2%,再次肺动脉瓣置换率为6.8%。
  • 年龄35岁被确定为与晚期死亡相关的最佳截断值。
  • >35岁患者10年死亡风险为<35岁者的5.6倍(10.4% vs 1.3%,P<0.001)。
  • >35岁患者合并三尖瓣修复/置换(15.1% vs 5.7%,P<0.001)和外科心律失常治疗(18.4% vs 5.9%,P<0.001)的比例更高。
  • 在<50岁患者中,晚期死亡风险为一般人群的8.7倍,>35岁行肺动脉瓣置换者风险高于<35岁者(风险比9.9 vs 7.4)。

临床怎么用

  • 对于法洛四联症修复后需行肺动脉瓣置换的患者,应关注年龄因素,>35岁者术后死亡风险显著增高。
  • 临床决策时应综合评估干预时机,避免因延迟手术导致不良结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Many adults with repaired tetralogy of Fallot will require a pulmonary valve replacement (PVR), but there is no consensus on the best timing. In this study, we aim to evaluate the impact of age at PVR on outcomes. METHODS: This is a national multicentre retrospective study including all patients >15 years of age with repaired tetralogy of Fallot who underwent their first PVR between 2000 and 2013. The optimal age cut-off was identified using Cox regression and classification and regression tree analysis. RESULTS: A total of 707 patients were included, median age 26 (15-72) years. The mortality rate at 10 years after PVR was 4.2%, and the second PVR rate of 6.8%. Age at PVR of 35 years was identified as the optimal cut-off in relation to late mortality. Patients above 35 years of age had a 5.6 fold risk of death at 10 years compared with those with PVR under 35 years (10.4% vs 1.3%, P < 0.001), more concomitant tricuspid valve repair/replacement (15.1% vs 5.7%, P < 0.001) and surgical arrhythmia treatment (18.4% vs 5.9%, P < 0.001). In those under 50 years, there was an 8.7 fold risk of late death compared with the general population, higher for those with PVR after 35 than those with PVR below 35 years (hazard ratio 9.9 vs 7.4). CONCLUSIONS: Patients above 35 years of age with repaired tetralogy of Fallot have significantly worse mortality after PVR, compared with younger patients and a higher burden of mortality relative to the general population. This suggests that there are still cases where the timing of initial PVR is not optimal, warranting a re-evaluation of criteria for intervention.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Dorobantu DM, Sharabiani MTA, Taliotis D, et al. Age over 35 years is associated with increased mortality after pulmonary valve replacement in repaired tetralogy of Fallot: results from the UK National Congenital Heart Disease Audit database. Eur J Cardiothorac Surg. 2020. PMID: 32187367. doi:10.1093/ejcts/ezaa069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。